November 4, 2026 | TickerRoast Markets Analysis
CVS Health shares fell 12.5% to $79.96 as of the Nov 4, 2026 close, according to Yahoo Finance data, after the company paired a third-quarter beat with a plan to break itself in two. The decline came on a session when the Dow gained 3%, according to Yahoo Finance data.
A Breakup Announced the Same Morning as a Raise
CVS had two pieces of news on Wednesday morning. In its third-quarter release, the company reported total revenue of $108.4 billion, up 5.4% year over year, and adjusted EPS of $2.09 against $1.60 a year earlier. It raised its full-year adjusted EPS guidance to at least $8.20 from a prior range of $7.90 to $8.10, and lifted its cash flow from operations target to at least $15.5 billion from at least $11.5 billion. According to 24/7 Wall St., the quarterly adjusted EPS figure beat a $1.65 consensus estimate.
In a separate release filed the same day, CVS said its board intends to separate the company into two publicly traded businesses. One, which will keep the CVS Health name for now, would hold Aetna, CVS Caremark, CVS Specialty, Oak Street Health and Signify Health. The other, to be called CVS Pharmacy, would take roughly 9,000 retail pharmacies, mail pharmacy, MinuteClinic and the Health100 technology business. The company expects to complete the separation in the first half of 2028 and intends it to be tax-free to shareholders.
The Market Reaction
According to 24/7 Wall St., shares fell about 12% after the split announcement. For most of the past decade, CVS’s strategy rested on the idea that owning the insurer, the pharmacy benefit manager and the store network under one roof would produce cost advantages that rivals could not match.
Management addressed separation costs. According to 24/7 Wall St., chief financial officer Brian Newman described separation costs as “certainly manageable.”
The Quarter Under the Headline
| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Total revenue | $108.4B | $102.9B |
| Adjusted EPS | $2.09 | $1.60 |
| GAAP diluted EPS | $1.68 | ($3.13) |
| Health Care Benefits MBR | 91.3% | 92.8% |
| FY2026 adjusted EPS guide | At least $8.20 | Prior: $7.90-$8.10 |
The operating details showed improvement. The medical benefit ratio in the Health Care Benefits segment fell to 91.3% from 92.8%, which CVS attributed to improved performance in its government business, and adjusted operating income rose 21.2% across the company. The prior-year GAAP loss reflected a $5.7 billion goodwill impairment in Health Care Delivery. CVS also said more than 69% of its Aetna Medicare Advantage members are in 2027 plans rated four stars or higher. The company still described its outlook as cautious, citing elevated cost trends and the potential for macro headwinds.
A Heavy-Volume Session
Based on Yahoo Finance data, volume of roughly 34 million shares was about four times its three-month average, and the stock closed above its 52-week closing low of about $70.
Rivals Rallied While CVS Fell
The divergence inside managed care was striking. According to Yahoo Finance data, Elevance Health rose 4.9% and Cigna gained 3.4% on Wednesday. 24/7 Wall St. suggested those names were likely benefiting from a relative value trade. The wider market was strong too: the Dow rose 3.03% to 53,356.12 and the S&P 500 added 1.58%, according to Yahoo Finance data,.
What the Next Year Has to Prove
From here, the debate shifts from whether CVS can fix Aetna to how the two pieces will be capitalized. CVS said both companies are expected to carry solid investment-grade ratings and pay an attractive dividend, but it has not yet named most of the leadership or board members. Open questions include the allocation of debt between the two companies, any update on separation costs, Aetna’s 2027 Medicare Advantage pricing and membership, and whether Washington’s new balance of power changes the regulatory backdrop for Caremark. The fourth-quarter report early next year will be the first test of whether the raised 2026 targets hold.
Sources
- CVS Health Corporation Reports Third Quarter 2026 Results (Exhibit 99.1) — CVS Health / SEC EDGAR
- CVS Health Announces Intent to Create Two Distinct Leaders in Healthcare (Exhibit 99.1) — CVS Health / SEC EDGAR
- CVS Tumbles 12% on Plan to Split Into Two Companies Despite Earnings Beat — 24/7 Wall St.
- CVS Health (CVS) price history — Yahoo Finance
Market data: Yahoo Finance, close of 2026-11-04. Charts generated by TickerRoast from this data.
AI disclosure: This article was drafted with AI tools (Claude, by Anthropic) from the sources listed above and reviewed by the editor before publication.
Disclaimer: This article is for informational and educational purposes only. It provides general financial and business analysis and does not constitute investment advice, a personal recommendation, a recommendation to buy, sell or hold any security, or an offer to transact in any financial instrument. Information is based on publicly available sources as of November 4, 2026 and market data as of the 2026-11-04 close (Yahoo Finance). Past performance is not a reliable indicator of future results; forecasts are uncertain and actual results may differ materially. Investing in shares involves risk, including the loss of capital. The publisher does not guarantee the accuracy or completeness of the information and accepts no responsibility for investment decisions made on the basis of this article. Readers should consult official company disclosures, conduct their own research and, where appropriate, seek advice from a licensed financial adviser. Conflicts of interest: At the time of writing, the author and TickerRoast have no position in the securities mentioned and receive no compensation from the companies discussed.
Read next
Get the daily market briefing
The stories that move markets, in your inbox every trading day at 9 a.m. ET. Free, unsubscribe anytime.
